The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background. Elevated plasma low-density lipoprotein cholesterol (LDL-C) is the main risk factor for atherosclerotic cardiovascular disease (ASCVD). Statins are the drugs of choice for decreasing LDL-C and are used for the prevention and management of ASCVD. Guidelines recommend that subjects with hi...
Saved in:
Main Authors: | Tannaz Jamialahmadi, Fatemeh Baratzadeh, Željko Reiner, Luis E. Simental-Mendía, Suowen Xu, Andrey V. Susekov, Raul D. Santos, Amirhossein Sahebkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/9661752 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statins—Their Effect on Lipoprotein(a) Levels
by: Marcin Mateusz Granat
Published: (2025-01-01) -
Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer's disease management
by: Yixiang Hu, et al.
Published: (2025-02-01) -
Response to letter to the editor: Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer’s disease management
by: Mar Garcia–Zamora, et al.
Published: (2025-02-01) -
Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01) -
Statins as Modulators of Regulatory T-Cell Biology
by: David A. Forero-Peña, et al.
Published: (2013-01-01)